Inventor · disambiguated record
Jeffrey Strovel
Also filed as: STROVEL JEFFREY · STROVEL JEFFREY W · STROVEL JEFFREY WILLIAM
10 granted patents·8 pending applications·125 citations·filing 2003–2020
86Inventor score
Files withCONVERGENE LLC7AVALON PHARMACEUTICALS4CHOLODY WIESLAW M2AUGUSTUS MEENA1DOGWOOD PHARMACEUTICALS INC1
Top patents by PatentIndex Score
18 records- 0193US8129519B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofCHOLODY WIESLAW M·Filed 2008·Granted Mar 6, 2012·97 cites·6 claims
- 0292US9695179B2Methods and compositions for inhibition of bromodomain-containing proteinsCONVERGENE LLC·Filed 2014·Granted Jul 4, 2017·22 cites·36 claims
- 0382US10508106B2Bicyclic BET bromodomain inhibitors and uses thereofCONVERGENE LLC·Filed 2016·Granted Dec 17, 2019·2 cites·2 claims
- 0479US10266536B2Methods and compositions for inhibition of bromodomain-containing proteinsCONVERGENE LLC·Filed 2017·Granted Apr 23, 2019·2 cites·29 claims
- 0578US7427473B2Chemo-centric selection of disease-related genetic profilesAVALON PHARMACEUTICALS·Filed 2005·Granted Sep 23, 2008·2 cites·27 claims
- 0667US10717739B2Methods and compositions for inhibition of bromodomain-containing proteinsCONVERGENE LLC·Filed 2019·Granted Jul 21, 2020·0 cites·19 claims
- 0758US11028079B2Small molecule BET bromodomain inhibitors and uses thereofCONVERGENE LLC·Filed 2019·Granted Jun 8, 2021·0 cites·14 claims
- 0854US9120754B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofCHOLODY WIESLAW M·Filed 2012·Granted Sep 1, 2015·0 cites·19 claims
- 0952US2004002091A1Cancer-linked gene as target for chemotherapyFiled 2003·Application pending·0 cites
- 1051US9446021B2Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereofDOGWOOD PHARMACEUTICALS INC·Filed 2015·Granted Sep 20, 2016·0 cites·15 claims
- 1151US2010015620A1Cancer-linked genes as biomarkers to monitor response to impdh inhibitorsSTROVEL JEFFREY W·Filed 2007·Application pending·0 cites
- 1249US2008025981A1Cancer-linked genes as targets for chemotherapyYOUNG PAUL E·Filed 2006·Application pending·0 cites
- 1348US12497395B2Small molecule bromodomain inhibitors and uses therofCONVERGENE LLC·Filed 2020·Granted Dec 16, 2025·0 cites·13 claims
- 1445US2010249111A1Multi-ring compounds and uses thereofAVALON PHARMACEUTICALS·Filed 2008·Application pending·0 cites
- 1541US2006134622A1Amplified cancer target genes useful in diagnosis and thereapeutic screeningAUGUSTUS MEENA·Filed 2003·Application pending·0 cites
- 1640US2007059697A1Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methodsAVALON PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1737US2008305493A1Determining Cancer-Linked Genes and Therapeutic Targets Using Molecular Cytogenetic MethodsAVALON PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 1835US2019092761A1Methods and Compositions for Inhibition of Bromodomain and Extratermial ProteinsCONVERGENE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Strovel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →